Clinical Trial Update: Variation in Sulphonylurea Response in Type 2 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 trial investigating variability in response to sulphonylurea therapy in type 2 diabetes was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Sulphonylurea (class) (sulphonylurea class)

Snippet

Sponsor: NHS Tayside | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: TERMINATED